Tari AM - Search Results

1

A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA, Tari AM. Simeone AM, et al. Among authors: tari am. Mol Cancer Ther. 2002 Oct;1(12):1009-17. Mol Cancer Ther. 2002. PMID: 12481423

2

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.

Simeone AM, Broemeling LD, Rosenblum J, Tari AM. Simeone AM, et al. Among authors: tari am. Oncogene. 2003 Oct 2;22(43):6739-47. doi: 10.1038/sj.onc.1206786. Oncogene. 2003. PMID: 14555987

3

Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.

Lim SJ, Simeone AM, Kim CK, Tari AM. Lim SJ, et al. Among authors: tari am. Int J Cancer. 2002 Sep 20;101(3):243-7. doi: 10.1002/ijc.10596. Int J Cancer. 2002. PMID: 12209974

4

Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells.

Simeone AM, Li YJ, Broemeling LD, Johnson MM, Tuna M, Tari AM. Simeone AM, et al. Among authors: tari am. Cancer Res. 2004 Feb 15;64(4):1224-8. doi: 10.1158/0008-5472.can-03-2188. Cancer Res. 2004. PMID: 14973114

5

N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.

Simeone AM, Deng CX, Kelloff GJ, Steele VE, Johnson MM, Tari AM. Simeone AM, et al. Among authors: tari am. Carcinogenesis. 2005 May;26(5):1000-7. doi: 10.1093/carcin/bgi038. Epub 2005 Feb 3. Carcinogenesis. 2005. PMID: 15695235

6

Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cells.

Tari AM, Simeone AM, Li YJ, Gutierrez-Puente Y, Lai S, Symmans WF. Tari AM, et al. Lab Invest. 2005 Nov;85(11):1357-67. doi: 10.1038/labinvest.3700339. Lab Invest. 2005. PMID: 16127422 Free article.

7

N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.

Simeone AM, Colella S, Krahe R, Johnson MM, Mora E, Tari AM. Simeone AM, et al. Among authors: tari am. Carcinogenesis. 2006 Mar;27(3):568-77. doi: 10.1093/carcin/bgi233. Epub 2005 Sep 30. Carcinogenesis. 2006. PMID: 16199439

8

Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.

Nieves-Alicea R, Colburn NH, Simeone AM, Tari AM. Nieves-Alicea R, et al. Among authors: tari am. Breast Cancer Res Treat. 2009 Mar;114(2):203-9. doi: 10.1007/s10549-008-9993-5. Epub 2008 Apr 4. Breast Cancer Res Treat. 2009. PMID: 18386173 Free PMC article.

9

JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.

McMurtry V, Saavedra JE, Nieves-Alicea R, Simeone AM, Keefer LK, Tari AM. McMurtry V, et al. Among authors: tari am. Int J Oncol. 2011 Apr;38(4):963-71. doi: 10.3892/ijo.2011.925. Epub 2011 Jan 25. Int J Oncol. 2011. PMID: 21271218 Free PMC article.

10

TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells.

Simeone AM, McMurtry V, Nieves-Alicea R, Saavedra JE, Keefer LK, Johnson MM, Tari AM. Simeone AM, et al. Among authors: tari am. Breast Cancer Res. 2008;10(3):R44. doi: 10.1186/bcr2095. Epub 2008 May 12. Breast Cancer Res. 2008. PMID: 18474097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters